5/1
07:15 am
prax
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $117.00 price target on the stock.
Low
Report
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $117.00 price target on the stock.
5/1
05:23 am
prax
Rating for PRAX
Low
Report
Rating for PRAX
5/1
05:23 am
prax
Rating for PRAX
Low
Report
Rating for PRAX
4/30
04:08 pm
prax
Praxis Precision Medicines initiated with bullish view at Baird
Low
Report
Praxis Precision Medicines initiated with bullish view at Baird
4/30
04:08 pm
prax
Praxis Precision Medicines initiated with bullish view at Baird
Low
Report
Praxis Precision Medicines initiated with bullish view at Baird
4/26
08:11 am
prax
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $105.00 price target on the stock.
Low
Report
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $105.00 price target on the stock.
3/26
01:31 pm
prax
Rating for PRAX
Medium
Report
Rating for PRAX
3/26
01:31 pm
prax
Rating for PRAX
Medium
Report
Rating for PRAX
3/26
12:26 pm
prax
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $105.00 price target on the stock.
Medium
Report
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $105.00 price target on the stock.
3/6
08:10 am
prax
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $105.00 price target on the stock.
Medium
Report
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $105.00 price target on the stock.